EPA:EQS - Euronext Paris - Matif - FR0012882389 - Common Stock - Currency: EUR
Taking everything into account, EQS scores 6 out of 10 in our fundamental rating. EQS was compared to 11 industry peers in the Health Care Technology industry. EQS scores excellent points on both the profitability and health parts. This is a solid base for a good stock. EQS has a decent growth rate and is not valued too expensively.
Industry Rank | Sector Rank | ||
---|---|---|---|
ROA | 9.1% | ||
ROE | 15.65% | ||
ROIC | 12.02% |
Industry Rank | Sector Rank | ||
---|---|---|---|
OM | 20.18% | ||
PM (TTM) | 16.72% | ||
GM | 68.77% |
Industry Rank | Sector Rank | ||
---|---|---|---|
Debt/Equity | 0.12 | ||
Debt/FCF | 1.29 | ||
Altman-Z | 4.54 |
Industry Rank | Sector Rank | ||
---|---|---|---|
Current Ratio | 1.21 | ||
Quick Ratio | 1.1 |
Industry Rank | Sector Rank | ||
---|---|---|---|
PE | 21.05 | ||
Fwd PE | 17.23 |
Industry Rank | Sector Rank | ||
---|---|---|---|
P/FCF | 21.25 | ||
EV/EBITDA | 12.43 |
Industry Rank | Sector Rank | ||
---|---|---|---|
Dividend Yield | 2.46% |
EPA:EQS (5/29/2025, 2:15:02 PM)
50.3
+0.3 (+0.6%)
Industry Rank | Sector Rank | ||
---|---|---|---|
Dividend Yield | 2.46% |
Industry Rank | Sector Rank | ||
---|---|---|---|
PE | 21.05 | ||
Fwd PE | 17.23 | ||
P/S | 3.52 | ||
P/FCF | 21.25 | ||
P/OCF | 16.05 | ||
P/B | 3.3 | ||
P/tB | 9.35 | ||
EV/EBITDA | 12.43 |
Industry Rank | Sector Rank | ||
---|---|---|---|
ROA | 9.1% | ||
ROE | 15.65% | ||
ROCE | 14.76% | ||
ROIC | 12.02% | ||
ROICexc | 14.31% | ||
ROICexgc | 35.95% | ||
OM | 20.18% | ||
PM (TTM) | 16.72% | ||
GM | 68.77% | ||
FCFM | 16.57% |
Industry Rank | Sector Rank | ||
---|---|---|---|
Debt/Equity | 0.12 | ||
Debt/FCF | 1.29 | ||
Debt/EBITDA | 0.48 | ||
Cap/Depr | 79.39% | ||
Cap/Sales | 5.37% | ||
Interest Coverage | 250 | ||
Cash Conversion | 81.41% | ||
Profit Quality | 99.11% | ||
Current Ratio | 1.21 | ||
Quick Ratio | 1.1 | ||
Altman-Z | 4.54 |